8-K: FitLife Brands Reports Q4, Full-Year 2025 Results

FitLife Brands announced its fourth quarter and full-year 2025 financial results, highlighted by significant revenue growth driven by the Irwin Naturals acquisition, alongside declines in net income and EPS.

Summary

• Total revenue for Q4 2025 increased 73% to $25.9 million, and full-year 2025 revenue increased 26% to $81.5 million, primarily due to the Irwin Naturals acquisition.
• Net income for Q4 2025 decreased to $1.6 million from $2.1 million in Q4 2024, and full-year net income decreased to $6.3 million from $9.0 million in 2024.
• Diluted EPS for Q4 2025 was $0.16, down from $0.21 in Q4 2024, and full-year diluted EPS was $0.63, down from $0.91 in 2024.
• Adjusted EBITDA for Q4 2025 increased 14% to $3.5 million, while full-year Adjusted EBITDA saw a slight 1% decrease to $14.0 million.
• The acquisition of Irwin Naturals was completed on August 8, 2025, contributing $11.2 million in wholesale revenue in Q4 2025.
• Irwin's online sales on Amazon scaled rapidly, reaching approximately $0.5 million in December 2025 and $0.8 million monthly post-quarter.
• Legacy FitLife brands experienced a 12% revenue decline in Q4 2025, with online revenue down 10% and wholesale revenue down 14%.
• The company ended 2025 with $39.1 million outstanding on its term loan and $5.6 million on its revolving line of credit, with total net debt of approximately $43.1 million.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed report with significant revenue growth driven by acquisition, but underlying profitability and organic growth in legacy segments are concerning, compounded by a cautious outlook on consumer spending.

Positives

• Total revenue increased significantly by 73% in Q4 2025 to $25.9 million and 26% for the full year to $81.5 million.
• Wholesale revenue more than tripled in Q4 2025 to $15.5 million and increased 84% for the full year to $39.7 million.
• Adjusted EBITDA increased 14% in Q4 2025 to $3.5 million.
• The Irwin Naturals acquisition contributed $11.2 million in wholesale revenue in Q4 2025 and showed approximately 6% organic growth in its first full quarter.
• Irwin's online sales on Amazon scaled from zero to $0.5 million in December 2025, with continued growth to approximately $0.8 million monthly post-Q4, representing a ~$9-10 million annual run rate with higher margins.
• Other Legacy FitLife brands (excluding MRC and MusclePharm) delivered 6% organic growth, and MusclePharm delivered 5% organic growth in 2025.
• The company began paying down debt in Q4 2025, with a $1.5 million term loan amortization and $0.4 million revolver reduction, and further reductions in Q1 2026.

Negatives

• Net income decreased to $1.6 million in Q4 2025 from $2.1 million in Q4 2024, and to $6.3 million for the full year 2025 from $9.0 million in 2024.
• Basic and diluted earnings per share declined in both Q4 2025 and full-year 2025 compared to the prior periods.
• Gross margin (excluding inventory step-up) declined to 37.0% in Q4 2025 (from 41.4%) and 39.9% for the full year (from 43.6%), primarily due to the lower gross margin profile of the acquired Irwin business.
• Online revenue for the full year 2025 decreased 3% to $41.8 million.
• Legacy FitLife revenue declined 12% in Q4 2025, with online revenue down 10% and wholesale revenue down 14%.
• MRC revenue declined 15% over the course of 2025.
• Adjusted EBITDA for the full year 2025 decreased 1% to $14.0 million.
• Cash and cash equivalents decreased to $1.646 million at December 31, 2025, from $4.468 million at December 31, 2024.
• Net cash provided by operating activities decreased to $7.439 million in 2025 from $9.610 million in 2024.

Risks

• Emerging weakness observed across most brands and channels in late Q4 2025 and persisting into Q1 2026.
• Broad-based consumer confidence concerns due to economic and political volatility, leading to declining consumer discretionary spending (lowest in four years).
• Uncertainty whether Irwin's online growth will fully or partially offset weakness elsewhere in the business.
• Ability of the company to continue to grow revenue.
• Ability of the company to continue to achieve positive cash flow given existing and anticipated operating and other costs.
• General known and unknown risks and uncertainties that may cause actual results to differ materially from forward-looking statements.

Future Outlook

The company anticipates continued weakness across most brands and channels in Q1 2026 due to broad-based consumer confidence concerns and declining discretionary spending. Management is focused on five key initiatives: improving Irwin's supply chain, increasing new product development at Irwin, driving off-Amazon demand, leveraging Irwin's sales team for cross-selling, and reducing SG&A through operating efficiencies. While encouraged by Irwin's online growth, particularly on Amazon, it is uncertain if this will fully offset the broader business weakness.

Management Comments

• "Other than at MRC, where revenue declined 15% over the course of the year, 2025 was a strong year for all of our brand groupings."
• "Excluding MRC and MusclePharm, the other Legacy FitLife brands delivered organic growth of 6%."
• "MusclePharm delivered organic growth of 5%, with growth in both the online and wholesale channels."
• "And in its first full quarter of ownership, Irwin delivered organic growth of 6%."
• "We intend to continue allocating our available free cash flow to debt reduction."
• "During the first quarter of 2026, this weakness has persisted across most brands and channels."
• "Consumer sentiment remains near all-time lows, and consumer discretionary spending has been declining since late last year and is at the lowest level it has been in the past four years."
• "I am encouraged by the continued growth of online revenue for Irwin, particularly on Amazon."
• "The online growth we are experiencing at Irwin is encouraging, but at this point we are not able to determine whether it will fully or only partially offset the weakness we are experiencing elsewhere in our business."

Industry Context

StockSavvy.ai notes that FitLife Brands' performance reflects a mixed industry landscape. While strategic acquisitions like Irwin Naturals can drive significant top-line growth, the broader consumer discretionary market faces headwinds from declining consumer confidence and spending, as highlighted by management. The shift towards online channels, particularly Amazon, for acquired brands like Irwin, demonstrates a key industry trend for reaching health-conscious consumers, but overall market softness remains a challenge for legacy brands.

Stakeholder Impact

• Shareholders: Potential for increased revenue from acquisitions and strategic initiatives, but diluted earnings and declining gross margins, coupled with increased debt, may concern investors. The cautious outlook on consumer spending could impact future returns.
• Employees: Focus on operating efficiencies and SG&A reduction could imply potential restructuring or workforce adjustments.
• Customers: New product development for Irwin and efforts to drive demand off-Amazon suggest expanded product offerings and accessibility.
• Creditors: Debt reduction efforts indicate a commitment to managing liabilities, which is positive for creditors, but the increased overall debt load from the acquisition warrants monitoring.
• Suppliers: Improvement in Irwin's supply chain could lead to more stable and efficient relationships.

Next Steps

• Continue allocating available free cash flow to debt reduction.
• Drive meaningful improvement in Irwin's supply chain.
• Increase focus on new product development at Irwin.
• Drive awareness and demand generation for products off-Amazon.
• Leverage Irwin's sales team to cross-sell other FitLife products into the wholesale channel.
• Reduce SG&A through operating efficiencies.
• Hold an investor conference call on April 1, 2026, at 4:30 pm ET.

Key Dates

Recommendation

While FitLife Brands demonstrated strong top-line growth driven by the Irwin Naturals acquisition and promising Amazon sales for Irwin, the decline in net income, EPS, and gross margins, coupled with a cautious outlook on consumer discretionary spending and weakness in legacy brands, suggests a 'hold' position. The company is actively addressing challenges through strategic initiatives and debt reduction, but the uncertainty regarding the offset of broader business weakness by Irwin's growth warrants a wait-and-see approach for seasoned investors.

Keywords

Nutritional Supplements, Wellness Products, FitLife Brands, FTLF, Irwin Naturals, Acquisition, Financial Results, Earnings, Revenue Growth, EBITDA, Consumer Discretionary, Debt Reduction, Amazon Sales, Wholesale Revenue, Online Revenue, Supply Chain, New Product Development, SG&A Reduction